Brief: Cerevel Therapeutics Appoints Paul Burgess As Chief Business Development Officer
15/06/2023 11:51
June 15 (Reuters) - Cerevel Therapeutics Holdings Inc
CERE.O :
* CEREVEL THERAPEUTICS APPOINTS PAUL BURGESS AS CHIEF
BUSINESS
DEVELOPMENT AND STRATEGIC OPERATIONS OFFICER
Source text for Eikon: ID:nGNX4Q5WHm
Further company coverage: CERE.O
Recent news on Cerevel Therapeutics Holdings
See all newsBrief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands